Anika Therapeutics (ANIK) Tops Q4 EPS by 21c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. GOOGL
9. RTX
10. S

Go back to Anika Therapeutics (ANIK) Tops Q4 EPS by 21c

Anika Reports Fourth Quarter and Full Year 2018 Financial Results

February 21, 2019 4:05 PM EST

Strong Bottom Line Performance with $0.54 Diluted EPS for Fourth Quarter of 2018

MONOVISC and CINGAL Global Revenue Increased 14% for Full Year of 2018

BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary... More